Verteporfin roundtable 2000 and 2001 participants. Guidelines for using verteporfin (Visudyne^【○!R】) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes. Retina. 2002, 22, 6-18
Treatment of age-related macular degeneration with photodynamic therapy (TAP) study group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. One-year results of 2 randomized clinical trials-TAP Report 1. Arch Ophthalmol. 1999, 117, 1329-1345
The Japanese age-related macular degeneration trial (JAT) study group. Japanese age-related macular degeneration trial : 1-year results of photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration. Am J Ophthalmol. 2003, 136, 1049-1061
Verteporfin in photodynamic therapy study group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration : two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-Verteporfin in photodynamic therapy report 2. Am J Ophthalmol. 2001, 131, 541-560